Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
CRISPR and crRNAs02:53

CRISPR and crRNAs

16.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.6K
Homologous Recombination02:31

Homologous Recombination

50.1K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation and characterization of mesenchymal stem cells from caprine umbilical cord tissue matrix.

Tissue & cell·2016
Same author

Secretome Cues Modulate the Neurogenic Potential of Bone Marrow and Dental Stem Cells.

Molecular neurobiology·2016
Same author

Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2016
Same author

Influence of immobilization and forced swim stress on the neurotoxicity of lambda-cyhalothrin in rats: Effect on brain biogenic amines and BBB permeability.

Neurotoxicology·2016
Same author

Isolation and characterization of alborixin from Streptomyces scabrisporus: A potent cytotoxic agent against human colon (HCT-116) cancer cells.

Chemico-biological interactions·2016
Same author

Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement.

Indian journal of endocrinology and metabolism·2016
Same journal

Artificial intelligence-driven multi-omics analysis of gut-kidney axis in chronic kidney disease.

Progress in molecular biology and translational science·2026
Same journal

Artificial intelligence in multi-omics analysis of heart diseases.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis of type 2 diabetes.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis in AMR.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis of COVID-19 patient data.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis of liver diseases.

Progress in molecular biology and translational science·2026
See all related articles

Related Experiment Video

Updated: Jun 1, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.1K

Current progress in CRISPR-Cas systems for rare diseases.

Juveriya Israr1, Ajay Kumar2

  • 1Institute of Biosciences and Technology, Shri Ramswaroop Memorial University, Barabanki, Uttar Pradesh, India.

Progress in Molecular Biology and Translational Science
|January 17, 2025
PubMed
Summary
This summary is machine-generated.

CRISPR-Cas gene editing precisely alters genetic code, offering revolutionary treatments for rare diseases. Advanced CRISPR technologies enhance safety and efficacy for genetic therapies.

Keywords:
CRISPER-Cas systemsClinical trialsGenome editingPrecision medicineRare diseasesTherapeutic applications

More Related Videos

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

21.5K
A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
08:20

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

Published on: September 2, 2021

4.1K

Related Experiment Videos

Last Updated: Jun 1, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.1K
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

21.5K
A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
08:20

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

Published on: September 2, 2021

4.1K

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • CRISPR-Cas is a bacterial defense system against viruses.
  • It functions as a programmable DNA-cutting system using guide RNA and Cas enzymes.
  • This technology enables precise genetic modifications.

Purpose of the Study:

  • To explore the profound influence of CRISPR-Cas technology on molecular biology and genetics.
  • To highlight its potential in gene function research, disease modeling, and genetic therapy.
  • To discuss its transformative impact on biotechnology, agriculture, and personalized medicine.

Main Methods:

  • Utilizes guide RNA to direct Cas enzymes to specific genomic targets.
  • Cas enzymes cleave DNA for gene insertion, deletion, or modification.
  • Advanced methods like base and prime editing allow precise DNA alterations without double-strand breaks.

Main Results:

  • CRISPR-Cas enables accurate correction of genetic flaws underlying rare diseases.
  • Offers potential for targeted and effective treatments for rare medical conditions.
  • Improved safety and precision in gene editing reduce adverse effects.

Conclusions:

  • CRISPR-Cas technology is revolutionizing genetics and medicine, offering hope for rare disease cures.
  • Gene therapy using CRISPR-Cas holds promise for treating genetic disorders.
  • Ongoing research in CRISPR-Cas gene editing, delivery systems, and clinical trials is advancing rare disease treatment.